Stephen J. Bagley et al.
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Nature Cancer 2024
doi: 10.1038/s43018-023-00709-6
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Stephen J. Bagley et al.
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Nature Cancer 2024
doi: 10.1038/s43018-023-00709-6